Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 43.75
-0.90 (-2.02%)
At close: Mar 13, 2026
Center Laboratories Market Cap
Center Laboratories has a market cap or net worth of 32.66 billion as of March 13, 2026. Its market cap has increased by 10.44% in one year.
Market Cap
32.66B
Enterprise Value
36.72B
Revenue
1.52B
Ranking
n/a
PE Ratio
3.82
Stock Price
43.75
Market Cap Chart
Since November 3, 2004, Center Laboratories's market cap has increased from 358.01M to 32.66B, an increase of 9,022.77%. That is a compound annual growth rate of 23.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 32.66B | 5.17% |
| Dec 31, 2025 | 31.06B | -1.69% |
| Dec 31, 2024 | 31.59B | 3.14% |
| Dec 29, 2023 | 30.63B | 8.88% |
| Dec 30, 2022 | 28.13B | -7.93% |
| Dec 30, 2021 | 30.56B | -3.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 71.79B |
| Bora Pharmaceuticals | 58.73B |
| TTY Biopharm Company | 20.49B |
| Grape King Bio | 18.00B |
| ScinoPharm Taiwan | 17.00B |
| Synmosa Biopharma | 15.67B |
| YungShin Global Holding | 14.22B |
| Alar Pharmaceuticals | 12.96B |